CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
68.63
-1.17 (-1.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
CONMED Revenue
CONMED had revenue of $316.70M in the quarter ending September 30, 2024, with 3.98% growth. This brings the company's revenue in the last twelve months to $1.29B, up 10.23% year-over-year. In the year 2023, CONMED had annual revenue of $1.24B with 19.06% growth.
Revenue (ttm)
$1.29B
Revenue Growth
+10.23%
P/S Ratio
1.64
Revenue / Employee
$322,029
Employees
4,000
Market Cap
2.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% |
| Dec 31, 2022 | 1.05B | 34.84M | 3.45% |
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% |
| Dec 31, 2020 | 862.46M | -92.64M | -9.70% |
| Dec 31, 2019 | 955.10M | 95.46M | 11.11% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Premier | 1.33B |
| Omnicell | 1.06B |
| NeoGenomics | 644.12M |
| GeneDx Holdings | 267.23M |
| LeMaitre Vascular | 213.03M |
| Ligand Pharmaceuticals | 152.42M |
| Iovance Biotherapeutics | 90.86M |
| Geron | 29.48M |
CNMD News
- 11 days ago - CONMED Corporation Announces Quarterly Cash Dividend - Business Wire
- 26 days ago - Top 3 Health Care Stocks That May Dip This Month - Benzinga
- 4 weeks ago - CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference - Business Wire
- 6 weeks ago - CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20 - Business Wire
- 7 weeks ago - CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - CONMED Corporation Announces Third Quarter 2024 Financial Results - Business Wire
- 7 weeks ago - CONMED Corporation Announces Leadership Succession - Business Wire
- 2 months ago - CONMED Corporation Announces Preliminary Third Quarter Financial Information - Business Wire